In a group of 121 adult patients with end-stage chronic renal failure who had been undergoing maintenance haemodialysis for up to 10 years a number of biochemical variables have been measured and related to a set of objectiveradiologicalchanges in the same patients. The changes in plasma calcium, magnesium, phosphate, total protein, and albumin concentration did not distinguish the patients who were grouped on a radiological basis. Plasma alkaline phosphatase activity increased with the severity of the radiological findings but did not provide a sensitive discriminatory index between the different radiological groups. Plasma hydroxyproline concentration was found to be more sensitive than plasma alkaline phosphatase activity in detecting a radiological abnormality in some of the patients.
Renal osteodystrophy in patients undergoing maintenance haemodialysis therapy (M.H.T.) is progressive in the majority of patients (TatIer et al., 1973) . The biochemical changes which accompany renal osteodystrophy (R.O.D.) are of some diagnostic value and may also contribute towards an understanding of the natural history of the syndrome. However, studies of the total plasma concentrations of calcium and magnesium and of their fractions, and also of plasma alkaline phosphatase activity, showed these to be lacking in specificity and sensitivity (Varghese et al., 1973a) . Though the pathological processes in chronic renal failure may have an influence on both the mineral and organic components of the skeletal tissue, little is known about the interaction between these two phases. The study reported here was undertaken to extend the investigations mentioned above to a further and larger group of patients, and also to estimate plasma hydroxyproline, a non-essential amino acid which is reported to be a sensitive indicator of bone collagen metabolism (Laitinen. 1967; Hahn and Avioli, 1970; Varghese et al., 1973b) , and then to relate these biochemical findings to a set of objective radiological changes (Tatler et al., 1973) in the same patients.
PATIENTS AND METHODS
of calcium and 0.5 mmol of magnesium per litre. The patients were maintained on strict fluid and dietary control. The diet had a high caloric value and was low in sodium and potassium. All the patients were on treatment with aluminium-hydroxide gel.
For comparison with the control group the patients were subdivided into groups on the basis of a radiological survey undertaken on the same day as the biochemical investigations.
Group 1.-Control group, 39 normal healthy adults (17 men and 22 women) whose ages ranged from 19 to 60 years. All had normal renal function and no evidence of a disorder of calcium homoeostasis.
Group 2 Biochemical estimations were performed on a Blood collections control group of 39 normal adult subjects and a group of 121 adult patients with end-stage chronic Venous blood samples were collected without renal failure who had been on M.H.T. for up to stasis after a fast since the previous evening. Before 10 years. The patients were dialysed three times for blood collection the subjects were rested in the a total of 30 hours of dialysis per week, a Kiil supine position for one hour on a bed. In the patients dialyser and a warm single-pass dialysate system on M.H.T. specimens were collected between 36 and being used. The dialysis fluid contained 1.88 mmol 48 hours after the previous dialysis treatment. Gelatin, a known dietary source of hydroxyproline, was excluded from the diet of patients and controls for three days preceding the biochemical investigations.
Methods
Standard biochemical methods were used for the estimation of plasma calcium, phosphate, alkaline phosphatase, total protein, and albumin concentration (Varghese et al., 1973b) . Plasma hydroxyproline was measured on an ethanol extract by a modification of the method of Prockop and Udenfriend (1960) .
RESULTS
The biochemical findings for control subjects and patients are shown in Table I , together with the significance of the differences between patients and control subjects by Student's t test.
Calcium
The mean plasma calcium concentration was significantly increased in each group of patients in comparison with the control subjects. When com-parisons were made between the individual groups of patients, only in group 5 (those with evidence of extra-osseous calcification without subperiosteal erosions or fractures) did the plasma calcium concentration differ significantly (P < 0.05) from that in the other groups (I, 2, and 3).
Phosphate
The mean plasma phosphate concentration was significantly increased in each group of patients in comparison with the control subjects, and in group 3 as compared with group 5 (P < 0.05).
Magnesium
In each group of patients the mean plasma magnesium concentration was increased when compared with the control subjects. The mean magnesium concentration was significantly lower (P < 0.05) in group 3 (patients with evidence of subperiosteal erosions) than in group 5 (patients with soft tissue calcification without subperiosteal erosions or fractures).
Total protein and albumin
The mean total protein concentration of the patients' groups was not significantly different from that of the control group. In all groups of patients there was a significant reduction of the mean plasma albumin concentration in comparison with the control subjects,
Alkaline phosphatase
The mean plasma alkaline phosphatase activity for the control group was 5.95 K.A. units per 100 ml (S.D. = 1.64), giving a range of 2.7 to 9.2 K.A. units per 100 ml. This 'normal' range is somewhat lower than that generally accepted (3-13 KA. units per 100 ml) but is probably a reflection of the ages of the control subjects studied. The mean plasma alkaline phosphatase activity was significantly increased in all groups of patients in comparison with the control subjects. The highest values were found in the patients with subperiosteal erosions (group 3), in whom the mean plasma alkaline phosphatase activity was significantly increased as compared with the control group and as compared with the other groups of patients (P < 0.(01). The distribution of the individual results for plasma alkaline phosphatase activity are shown in Fig. 1 .
Plasma hydroxyproline
The mean plasma hydroxyproline concentration was significantly higher in all groups of patients than in the normal subjects. The hydroxyproline concentration was significantly increased (P < 0.(01) for the patients with subperiosteal erosions (group 3) in comparison with the other groups of patients; there were no significant differences between the other groups. The distribution of the individual results for plasma hydroxyproline concentration are shown in Fig. 2 . In group 3 there were no patients with values within the normal range found in the control subjects studied here, 0.4 to 2.8 mg/l (3,0 -21·3 /Lmol/l). When the discriminatory value of plasma hydroxyproline was compared (X 2 test) with alkaline phosphatase activity, plasma hydroxyproline was found to be more sensitive in detecting a radiologically recognizable abnormality in patients of group 3, 4, and 5 (P < 0.05) than alkaline phosphatase activity. The plasma hydroxyproline concentration correlated significantly (r = 0.689, P < 0.(01) with the alkaline phosphatase activity for all the patients when considered as one group (Fig. 3) . Only in the chronic renal failure patients of group 3, however, were these two variables significantly correlated (r = 0.630, P < 0.01).
DISCUSSION
The interpretation of biochemical findings in patients with chronic renal failure on M.H.T. is difficult because of the progressive changes which occur between one dialysis and the next. An attempt to overcome this problem has been made by taking all the blood samples at a standard time interval from the previous dialysis treatment. It is also recognized that the correlation of biochemical with radiological findings is difficult because of the slow progressive nature of the latter. Despite these limitations some of the biochemical findings appear to be of diagnostic value and show some correlation with the radiological appearances. The changes in plasma calcium, magnesium, phosphate, total protein, and albumin concentration, and in alkaline phosphatase activity did not distinguish between the groups of patients, and this is consistent with our earlier studies (Varghese et al., 1973a (Varghese et al., , 1973b .
In the absence of hepato-biliary disorders the plasma alkaline phosphatase activity reflects osteoblastic activity and as such is an index of bone remodelling. In all of the groups of patients studied here the mean plasma alkaline phosphatase activity was increased in comparison with the control subjects. The distribution of the individual results, however, showed that only in those patients with subperiosteal erosions (group 3) did the values for alkaline phosphatase activity reflect the radiological finding of the presence of metabolic bone disease. It would appear, therefore, that the alkaline phosphatase activity increases with the severity of the radiological findings but does not provide a sensitive discriminatory index between the different radiological groups.
Hydroxyproline is a non-essential amino acid which is found almost exclusively in collagen, where it constitutes approximately 14% of the amino acid residues. Collagen is the most abundant species of protein in the body, and the major portion of the total body collagen is in bone, constituting more than 90 % of the organic matrix (Hahn and Avioli, 1970) . Bone collagen is metabolically more active than other forms of collagen, and changes in plasma hydroxyproline concentration and urine hydroxyproline excretion are considered to reflect changes in bone metabolism. In all of the groups of patients studied the mean plasma hydroxyproline concentration was significantly increased. The most marked increase was in the patients with radiological evidence of subperiosteal bone resorption (group 3), and none of the patients in that group had values within the normal range. The distribution of the individual results for plasma hydroxyproline concentration showed that the majority of the results in every group of patients were above the upper limit of the normal range.
The increase in hydroxyproline concentration in those patients with no radiologically recognizable bone disease could be due to the lack of sensitivity of radiology in the assessment of metabolic bone disease or it could be due to the uraemic process per se. Avioli et al. (1969) found increased plasma hydroxyproline values in five uraemic patients with normal skeletal x-rays and normal serum alkaline phosphatase activity. They also reported that the increased concentration of plasma hydroxyproline found in uraemic rats was due to an inhibition of hepatic hydroxyproline oxidase activity. However, studies after parathyroidectomy and after calcium infusions in patients with chronic renal failure (Varghese et al., 1973b; Moorhead et al., 1974) suggest that the catabolism of hydroxyproline is not much different in these patients from normal. compared the plasma hydroxyproline values with bone histology in patients with chronic renal failure and reported a significant association between excessive resorptive activity on bone biopsy and raised values of plasma hydroxyproline. They also found an increased plasma hydroxyproline concentration in a few patients with normal bone histology. Giordano (1972) reported that in uraemic patients the plasma hydroxyproline concentration was normal during the first year of dialysis treatment and that there was a gradual rise in the concentration from the second year onwards. He assumed that this rise was due to the development of bone disease. An increase in total bone turnover has been reported in uraemic patients (Nichols et al., 1969) .
This increased turnover of organic matrix of the bone seemed to be a feature of renal osteodystrophy but was similar to that seen in patients with 'uncomplicated hyperparathyroidism'. Though parathyroid hormone (P.T.H.) is thought both to enhance bone resorption and inhibit bone formation, a net increase in bone mass has often been observed in renaI osteodystrophy in man (Rasmussen and Bordier, 1973) . In animals there is evidence that P.T.R. causes increased breakdown of both newly synthesized and old bone collagen (Avioli and Prockop, 1967) . Laitinen (1967) reported an increased rate of bone collagen synthesis in rats treated with parathyroid extract. Hahn and Avioli (1970) showed that collagen maturation can be inhibited by the uraemic state, resulting in an accumulation of soluble collagen. They also observed an increase in mature collagen degradation as a result of secondary hyperparathyroidism. A significant correlation (P < 0.(01) between plasma hydroxyproline concentration and immunoreactive P.T.H. has been found in a group of patients with chronic renal failure on M.H.T. . Paterson and Fourman (1968) suggested that collagen maturation may be impaired by vitamin D deficiency. Therefore modulations seen in plasma hydroxyproline concentration in patients both with and without radiological evidence of bone disease may be reflections of changes taking place in the organic matrix of the bone as a result of various factors prevalent in the chronic uraemic state such as vitamin D deficiency and parathyroid hyperactivity. The present study, however, shows that plasma hydroxyproline is a useful biochemical marker of hyperparathyroidism in renal failure and is of considerable value in studying the course of R.O.D. in dialysed patients.
